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Objectives: AA-amyloidosis is a known complication of diseases associated with
chronic inﬂammation and often leads to renal insufﬁciency. Several case reports of
CF patients with AA-amyloidosis have been published but no systematic studies
have been performed. Therefore, aim of our study was to determine the prevalence
of preclinical AA-amyloidosis in CF patients with chronic P. aeruginosa infection.
Methods: 80 patients older than 14 years chronically infected with P. aeruginosa
were included.
A ﬁne needle subcutaneous fat aspiration was stained with Congo red and examined
in bright light, in polarized light and in ﬂuorescent light.
If amyloid was detected, classiﬁcation was performed by immunohistochemistry
and/or amino acid sequencing.
Results: All biopsies were performed without complications and were suitable for
examination. Amyloid could be detected in three out of the 80 biopsies. One of
these patients suffered from renal insufﬁciency due to AA-amyloidosis as detected
also by renal biopsy.
The extracted amyloid ﬁbril protein of another patient was of insulin origin resulting
of s.c. insulin treatment of diabetes mellitus for six years.
The biopsy of the third patient showed small amounts of amyloid in the ﬁrst but not
in the second biopsy (amyloid-subtype not classiﬁed) without presenting clinical
signs for AA-amyloidosis indicating one case of preclinical amyloidosis.
Conclusions: In our study, we could only detect one patient with preclinical
amyloidosis. AA-amyloidosis should not be confused with the locally insulin-
induced amyloid in fatty tissue in insulin-treated diabetes mellitus.
Supported by: Mukoviszidose e.V., Germany.
213 Airways surface liquid depletion causes MMP-12 dependent
emphysema in bENaC-overexpressing mice
S.C. Schubert1,3, J.B. Trojanek1,3, S. Diemer1,3, A. Cobos2,3, Z. Zhou1,
D.A. Treis1, L. Dai1, J. Schatterny1, S. Hirtz1, C. Schultz2,3, M.A. Mall1,3. 1Ped.
Pulmonology and CF Center, Dept. of Pediatrics III, University of Heidelberg,
Heidelberg, Germany; 2Dept. of Cell Biology and Biophysics, EMBL, Heidelberg,
Germany; 3EMBL-University of Heidelberg Molecular Medicine Partnership Unit,
Heidelberg, Germany
Previous studies demonstrated that increased airway Na+ absorption and airway
surface liquid (ASL) depletion in bENaC-overexpressing (bENaC-Tg) mice cause
CF-like lung disease with airway mucus obstruction, chronic airway inﬂammation
and emphysema. The goal of this study was to elucidate the mechanisms under-
lying emphysema formation in this murine model of CF lung disease. Because
protease/antiprotease imbalance has been implicated as an important mechanism
in emphysema pathogenesis, we ﬁrst determined mRNA levels of proteases (ma-
trix metalloproteinases [MMPs], cathepsins, neutrophil elastase) and antiproteases
(TIMP1, SLPI, a1-AT) by real-time RT-PCR demonstrating a marked and exclusive
increase of MMP-12 (also called macrophage elastase) expression in lungs from
bENaC-Tg mice compared to littermates. Second, by using novel MMP-12 speciﬁc
ﬂuorescent resonance energy transfer (FRET) sensors, we demonstrate that MMP-12
activity was signiﬁcantly elevated on alveolar macrophages from bENaC-Tg mice.
To deﬁne the role of MMP-12 in emphysema formation we crossed bENaC-Tg
mice with MMP-12 deﬁcient mice and found that bENaC-Tg mice lacking MMP-
12 (bENaC-Tg mice; MMP-12−/−) were protected from distal airspace enlargement.
Our results indicate that ASL depletion leads to macrophage activation and MMP-
12 secretion and identify MMP-12 as cause of emphysema in bENaC-Tg mice.
Further studies are required to determine the role of MMP-12 in CF patients.
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Increased airway Na+ absorption is a characteristic abnormality of cystic ﬁbrosis
(CF) airways and causes CF-like lung disease in bENaC-transgenic (Tg) mice.
Recent studies demonstrated that juvenile bENaC-Tg mice also exhibit spontaneous
allergic airway inﬂammation. We hypothesized that airway surface dehydration in
bENaC-Tg mice causes increased susceptibility for allergic airway inﬂammation
due to reduced pulmonary clearance of inhaled allergens. To test this hypothesis,
we induced allergic airway inﬂammation by repeated intratracheal instillations of
Aspergillus fumigatus extract (Af), i.e. natural aeroallergen, and compared total and
differential cell counts in bronchoalveolar lavage, pulmonary IL-13 expression, and
airway morphology in bENaC-Tg mice with wild-type littermates. We demonstrate
that elevation of airway eosinophils and pulmonary IL-13 caused by intrapulmonary
exposure to Af are signiﬁcantly increased in bENaC-Tg mice compared to wild-
type controls. Further, we show that genetic deletion of Stat6 critical for Th-2
signaling protects bENaC-Tg mice from airway eosinophilia, elevated IL-13, goblet
cell metaplasia and airway mucus obstruction. Our studies demonstrate that airway
surface dehydration, characteristic of CF airways, plays a critical role in the
pathogenesis of Stat6-dependent allergic airway inﬂammation. These ﬁndings are
consistent with a high incidence of allergic bronchopulmonary aspergillosis (ABPA)
and confounding allergic airway inﬂammation in CF patients.
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Although many reports have showed oxidative stress markers and a decreased
antioxidant capacity in CF airway lining ﬂuid, few studies have focused on the
intracellular oxidant/antioxidant balance.
The aim of this work was to evaluate the oxidation status in the lung of CFTR-KO
(CF) and wild-type (WT) mice at the cellular level and their capacity to respond
in vivo to oxidative challenge.
Intracellular levels of reactive oxygen species, lipid oxidation, GSH-peroxidase
and SOD activities were found signiﬁcantly increased in CF compared to WT. As
PRDX6 is a major lung antioxidant and the main detoxiﬁcation system for peroxi-
dized phospholipid (PC-OOH), its expression was further investigated. Q-RT-PCR,
immunoblot and immunohistochemistry analyses revealed that PRDX6 mRNA and
protein levels are increased in CF compared to WT. To evaluate the ability of CF
pulmonary cells to limit phospholipid peroxidation under oxidative stress, PC-OOH
(by HPLC) and PRDX6 expression levels were evaluated in response to paraquat
(PQ). PQ induced a dramatic PC-OOH increase and a marked decrease in PRDX6
expression in CF mice. 2D gels and mass spectrometry revealed different PRDX6
modiﬁcations in WT vs CF.
These results highlight a dramatic modiﬁcation of lung oxidant/antioxidant status, a
vulnerability to oxidative insult in CF lungs and present PRDX6 as a key component
in CF antioxidant failure. This impaired PC-OOH detoxiﬁcation mechanism may
lead to membrane dysfunction and activate redox-related signaling, contributing to
an exaggerated inﬂammatory response in CF lung.
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